Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+14.4%
5Y CAGR+70.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+14.4%/yr
Annual compound
5Y CAGR
+70.2%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
14.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$19.30M-4.5%
2024$20.22M+7.4%
2023$18.82M+46.2%
2022$12.88M+76.9%
2021$7.28M+438.8%
2020$1.35M+45.9%
2019$926000.00-